1. Aged from 7 months to
2. Available for entire study period and whose parent/legal guardian could be reached by
3. Healthy as determined by medical history, physical examination, and judgment of the
4. Parent/legal guardian had to be able to complete all relevant study procedures during
1. Previous vaccination with licensed or investigational pneumococcal vaccine.
2. A previous anaphylactic reaction to any vaccine or vaccine-related component.
3. Contraindication to vaccination with pneumococcal vaccine.
4. Bleeding diathesis or condition associated with prolonged bleeding time that would
contraindicate intramuscular injection.
5. Known or suspected immune deficiency or suppression.
6. History of culture-proven invasive disease caused by S pneumoniae.
7. Major known congenital malformation or serious chronic disorders.
8. Significant neurological disorder or history of seizure including febrile seizure, or
significant stable or evolving disorders such as cerebral palsy, encephalopathy,
hydrocephalus, or other significant disorders. Does not include resolving syndromes
due to birth trauma such as Erb palsy.
9. Receipt of blood products or gamma-globulin (including monoclonal antibodies) in the
last 3 months.
10. Participation in another investigational or interventional trial. Participation in
purely observational studies is acceptable.
11. Child is a direct descendant (child or grandchild) of a member of the study site